BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• BioMidwest

  Rebiotix Develops Microbiome Health Index to Identify Indicators for Microbiome Restoration

  Initial research indicates that Microbiome HealtMHI was established in partnership with data analytics firm, BioRankings, to enable a non-biased comparison of the efficacy of microbiome-based therapeutics.

  February 12, 2018

   · 

  4 min read
• Drug Development

  Santen Presents Phase I/II Data on DE-122 (Carotuximab) in Patients With Refractory Wet Age-Related Macular Degeneration

  No serious adverse events were reported.

  February 12, 2018

   · 

  3 min read
• Biotech Bay

  Pomona Valley Hospital Medical Center Adopting In-House IV Compounding with Omnicell’s IV Robotics

  PVHMC joins many leading health systems who are adopting recommendations by The ISMP for the implementation of automation and technology in sterile compounding.

  February 12, 2018

   · 

  4 min read
• Drug Development

  Audentes Therapeutics Announces Dosing of First Patient in VALENS, a Phase I/II Clinical Trial of AT342 for the Treatment of Crigler-Najjar Syndrome

  In addition to VALENS, the clinical development program for AT342 includes LUSTRO, a prospective natural history run-in study in Crigler-Najjar patients.

  February 12, 2018

   · 

  7 min read
• Drug Development

  Applied Therapeutics Initiates Phase I Trial for AT-001 In Diabetic Complications

  Applied today announced initiation of a Phase 1 clinical trial for AT-001, an oral small molecule in development for diabetic complications.

  February 12, 2018

   · 

  1 min read
• Pharm Country

  Camber Spine Technologies Announces First Implantations of SPIRA-C Open Matrix Cervical Interbody

  The first cases were performed successfully this past week with several surgeons across the country performing multilevel ACDF procedures.

  February 12, 2018

   · 

  3 min read
• Business

  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018

  Following the announcement, Veracyte will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the company’s financial results and provide a general business update.

  February 12, 2018

   · 

  1 min read
• Business

  Saama’s Life Science Ecosystem Helps Partners Leverage Its Award-Winning Clinical Data Analytics Solutions Without Replacing Existing Vendors

  Saama Technologies, a leading clinical data analytics company, has launched the Life Science Ecosystem for its partners.

  February 12, 2018

   · 

  4 min read
• Teva Announces U.S. Launch of QVAR RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol

  Teva announced today that QVAR RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is now commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the U.S.

  February 12, 2018

   · 

  10 min read
• 

  Biotech Bay

  DiaCarta Scores $45M Series B to Expand Its Liquid Biopsy Cancer Detection Platform & Services

  The second closing was led by Fortune Fountain Capital and was also subscribed to by Good Health Capita.

  February 12, 2018

   · 

  3 min read